Effectiveness, safety and drug survival of oral roflumilast for hidradenitis suppurativa

J Eur Acad Dermatol Venereol. 2024 Jul 1. doi: 10.1111/jdv.20222. Online ahead of print.

Authors

Nikolaj Holgersen¹, Valdemar Wendelboe Nielsen¹, Hans Christian Ring¹, Alexander Egeberg^{1

2}, Jacob P Thyssen^{1

2}, Mette Gyldenløve^{2

3}, Simon Francis Thomsen^{1

4}

Affiliations

¹ Department of Dermato-Venereology & Wound Healing Centre, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark.
² Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
³ Department of Dermatology and Allergy, Copenhagen University Hospital, Herlev and Gentofte, Denmark.
⁴ Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.

PMID: 38949093
DOI: 10.1111/jdv.20222

No abstract available

Publication types

Letter